An α2δ agonist of the L-calcium channel (230) induced pancreatic acinar cell adenomas and acinar cell adenocarcinomas, and Leydig cell adenomas in males and uterine endometrial polyps in females (33). Here, ATXN2L is linked to acinar cell carcinoma.